{"log_id": 6856781756692871300, "direction": 0, "words_result_num": 35, "words_result": [{"probability": {"variance": 0.009169, "average": 0.957246, "min": 0.571831}, "location": {"width": 1134, "top": 173, "height": 38, "left": 283}, "words": "发生率<1%:一过性、无症状的AST和/或ALT、胆红素升高。主要发生于高催吐化疗的患者"}, {"probability": {"variance": 0, "average": 0.999613, "min": 0.999428}, "location": {"width": 59, "top": 230, "height": 32, "left": 288}, "words": "代谢"}, {"probability": {"variance": 0.012964, "average": 0.950064, "min": 0.456384}, "location": {"width": 1147, "top": 283, "height": 38, "left": 285}, "words": "发生率1%:高钾血症;发生率<1%=电解质素乱、高血糖、代谢性酸中毒、尿糖、食欲减"}, {"probability": {"variance": 0.050378, "average": 0.774541, "min": 0.550091}, "location": {"width": 48, "top": 157, "height": 182, "left": 1540}, "words": "一证"}, {"probability": {"variance": 0.000539, "average": 0.978813, "min": 0.939265}, "location": {"width": 118, "top": 340, "height": 32, "left": 228}, "words": "退和厌食"}, {"probability": {"variance": 7.1e-05, "average": 0.9929, "min": 0.977599}, "location": {"width": 180, "top": 393, "height": 36, "left": 285}, "words": "骨骼肌肉系统"}, {"probability": {"variance": 0.005385, "average": 0.956191, "min": 0.811461}, "location": {"width": 276, "top": 450, "height": 36, "left": 285}, "words": "发生率<1%:关节痛"}, {"probability": {"variance": 1e-06, "average": 0.998379, "min": 0.997041}, "location": {"width": 121, "top": 509, "height": 34, "left": 288}, "words": "神经系统"}, {"probability": {"variance": 0.020143, "average": 0.921501, "min": 0.447162}, "location": {"width": 864, "top": 567, "height": 36, "left": 283}, "words": "发生率1%:头晕;发生率<1%:困,失眠,情绪亢进,感觉异常"}, {"probability": {"variance": 4e-05, "average": 0.995956, "min": 0.984948}, "location": {"width": 123, "top": 621, "height": 36, "left": 288}, "words": "精神系统"}, {"probability": {"variance": 0.022664, "average": 0.930495, "min": 0.393479}, "location": {"width": 523, "top": 679, "height": 34, "left": 288}, "words": "发生率1%:焦虑;发生率1%:欣快感"}, {"probability": {"variance": 5e-06, "average": 0.998688, "min": 0.995005}, "location": {"width": 123, "top": 733, "height": 36, "left": 288}, "words": "泌尿系统"}, {"probability": {"variance": 0.012825, "average": 0.926946, "min": 0.632462}, "location": {"width": 272, "top": 791, "height": 36, "left": 290}, "words": "发生率<1%:尿潴留"}, {"probability": {"variance": 7.1e-05, "average": 0.992636, "min": 0.978219}, "location": {"width": 121, "top": 848, "height": 36, "left": 290}, "words": "血管系统"}, {"probability": {"variance": 0.001384, "average": 0.983532, "min": 0.849455}, "location": {"width": 443, "top": 905, "height": 34, "left": 290}, "words": "发生率<1%:静脉变色、静脉扩张"}, {"probability": {"variance": 0, "average": 0.998971, "min": 0.998008}, "location": {"width": 98, "top": 960, "height": 34, "left": 244}, "words": "【禁忌】"}, {"probability": {"variance": 1.4e-05, "average": 0.998019, "min": 0.983611}, "location": {"width": 633, "top": 1015, "height": 36, "left": 290}, "words": "禁用于已知对该药物或药物中任何组份过敏的患者"}, {"probability": {"variance": 1.1e-05, "average": 0.99759, "min": 0.990389}, "location": {"width": 160, "top": 1069, "height": 36, "left": 242}, "words": "【注意事项】"}, {"probability": {"variance": 0.003786, "average": 0.977323, "min": 0.713422}, "location": {"width": 729, "top": 1127, "height": 34, "left": 299}, "words": "过敏反应可能发生于对其它选择性5-HT受体拮抗剂过敏者"}, {"probability": {"variance": 0.001202, "average": 0.98624, "min": 0.827785}, "location": {"width": 1129, "top": 1179, "height": 38, "left": 292}, "words": "在国外临床试验所研究的剂最水平下,帕洛诺司琼未观察到引起有临床意义的QTc间期延长"}, {"probability": {"variance": 0.018027, "average": 0.936561, "min": 0.454039}, "location": {"width": 1200, "top": 1236, "height": 38, "left": 235}, "words": "在221例健康成年男性和女性志愿者中进行的一项双育,随机、平行,安慰剂对照和阴性对赚(莫"}, {"probability": {"variance": 0.018478, "average": 0.937857, "min": 0.379194}, "location": {"width": 1154, "top": 1291, "height": 36, "left": 237}, "words": "西沙星)的完整的T/QTe研究中,评估了帕洛诺司琼对QTc间期的影响。结果显示在0.25m8"}, {"probability": {"variance": 0.003751, "average": 0.9702, "min": 0.72431}, "location": {"width": 1200, "top": 1346, "height": 38, "left": 235}, "words": "0.75mg,2.25mg剂量下均未观察到对QTc间期以及其它ECG的影响,也未观察到对心率、房室传"}, {"probability": {"variance": 0.008482, "average": 0.961342, "min": 0.466864}, "location": {"width": 1195, "top": 1401, "height": 41, "left": 237}, "words": "导和心脏复极化有临床意义的改变。但是基于其它5-HT受体持抗剂使用信息,对于伴随使用延"}, {"probability": {"variance": 0.022446, "average": 0.907205, "min": 0.410432}, "location": {"width": 1191, "top": 1460, "height": 43, "left": 237}, "words": "长Qr间期药物,以及患有或可能发展为Q间新长的人,应谨慎使用帕洛诺司琼。这些患者"}, {"probability": {"variance": 0.017168, "average": 0.942953, "min": 0.380789}, "location": {"width": 1198, "top": 1515, "height": 48, "left": 240}, "words": "包括:低钾血症或低镁血症者、服用尿药导异者、先天性QT综合症患者、服用抗"}, {"probability": {"variance": 0.033525, "average": 0.8902, "min": 0.408351}, "location": {"width": 1065, "top": 1566, "height": 52, "left": 240}, "words": "心律失常或其它药物可导致QT间何期延卡,和给高剂量环类药物治疗者"}, {"probability": {"variance": 0.009702, "average": 0.956594, "min": 0.554683}, "location": {"width": 1143, "top": 1639, "height": 41, "left": 297}, "words": "盐酸帕洛诺司琼注射液不能与其他药物混合故使用帕洛诺可琼注射液前、后均需应用生理"}, {"probability": {"variance": 0.008493, "average": 0.938588, "min": 0.735379}, "location": {"width": 230, "top": 1707, "height": 36, "left": 240}, "words": "盐水冲洗输注管路"}, {"probability": {"variance": 0.000421, "average": 0.987429, "min": 0.928462}, "location": {"width": 324, "top": 1758, "height": 36, "left": 308}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0.002569, "average": 0.972962, "min": 0.823306}, "location": {"width": 1131, "top": 1813, "height": 34, "left": 310}, "words": "尚未在妊娠妇女中进行充分的随机对照临床试验,也没有妊娠期或分娩期妇女使用过帕洛诺"}, {"probability": {"variance": 0.004936, "average": 0.970881, "min": 0.691739}, "location": {"width": 884, "top": 1865, "height": 36, "left": 237}, "words": "司琼:因此对其对母亲及胎儿的影响并不清楚,故怀孕期间应慎用本品"}, {"probability": {"variance": 0.01213, "average": 0.95326, "min": 0.467135}, "location": {"width": 1131, "top": 1920, "height": 36, "left": 308}, "words": "铂洛诺司琼是否通过乳汁分泌尚不明确。鉴于多数药物均经人体乳汁拌泄,对乳儿有潜在的"}, {"probability": {"variance": 0.00932, "average": 0.96584, "min": 0.470104}, "location": {"width": 1200, "top": 1970, "height": 41, "left": 240}, "words": "严重不良反应,且在大鼠致癌作压研究发现有潜在致癌作用。因此,应充分考虑使用药物的必要"}, {"probability": {"variance": 0.001181, "average": 0.983297, "min": 0.868313}, "location": {"width": 514, "top": 2030, "height": 36, "left": 246}, "words": "性之后,来决定是否停止哺乳或停止用药"}], "language": 3}